Description
Overview
This research blend combines CJC-1295 without DAC (5mg) with Ipamorelin (5mg) in a single vial. This combination targets both GHRH and ghrelin pathways for comprehensive growth hormone research.
Research Applications
- Synergistic GH secretion studies
- GHRH + GHSR pathway research
- Pulsatile release pattern investigations
- Combination secretagogue studies
Specifications
- CJC-1295 (no DAC): 5mg
- Ipamorelin: 5mg
- Total: 10mg per vial
- Purity: ≥99% each component
- Form: Lyophilized powder
- Storage: -20°C, protect from light
Reviews
There are no reviews yet.